Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Rituximab plus intravenous bolus chemotherapy is a standard treatment for immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL). Some studies have suggested that rituximab is associated with excessive toxicity in HIVassociated NHL, and that infusional chemotherapy may be more effective. We...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Sparano, Joseph A., Lee, Jeannette Y., Kaplan, Lawrence D., Levine, Alexandra M., Ramos, Juan Carlos, Ambinder, Richard F., Wachsman, William, Aboulafia, David, Noy, Ariela, Henry, David H., Von Roenn, Jamie, Dezube, Bruce J., Remick, Scot C., Shah, Manisha H., Leichman, Lawrence, Ratner, Lee, Cesarman, Ethel, Chadburn, Amy, Mitsuyasu, Ronald
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2010
Fag:
Clinical Trials and Observations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858478/
https://ncbi.nlm.nih.gov/pubmed/20023215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-08-231613
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker